Published in Perception on January 01, 1999
Chronic lymphocytic leukemic cells exhibit apoptotic signaling via TRAIL-R1. Cell Death Differ (2005) 1.90
Anaphylaxis to the chlorhexidine component of Instillagel: a case series. Br J Anaesth (2008) 1.82
Complications of obstetric regional analgesia: how much information is enough? Int J Obstet Anesth (2004) 1.39
Mucosal tolerance and suppression of collagen-induced arthritis (CIA) induced by nasal inhalation of synthetic peptide 184-198 of bovine type II collagen (CII) expressing a dominant T cell epitope. Clin Exp Immunol (1996) 1.27
Histone deacetylase inhibitors potentiate TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in lymphoid malignancies. Cell Death Differ (2004) 1.20
Prevention of pristane-induced arthritis by the oral administration of type II collagen. Immunology (1993) 1.05
NOXA, a sensor of proteasome integrity, is degraded by 26S proteasomes by an ubiquitin-independent pathway that is blocked by MCL-1. Cell Death Differ (2012) 1.00
Suppression of collagen induced arthritis by oral administration of type II collagen: changes in immune and arthritic responses mediated by active peripheral suppression. Autoimmunity (1993) 0.96
Costello syndrome. Paediatr Anaesth (1997) 0.93
Assessment of the effect upon maternal knowledge of an information leaflet about pain relief in labour. Anaesthesia (2003) 0.91
Cardiopulmonary exercise testing predicts postoperative outcome in patients undergoing gastric bypass surgery. Br J Anaesth (2012) 0.90
Effects of induced mast cell activation on prostaglandin E and metalloproteinase production by rheumatoid synovial tissue in vitro. Ann Rheum Dis (1998) 0.88
Synergistic activity of polynuclear aromatic hydrocarbon mixtures as aryl hydrocarbon (Ah) receptor agonists. Chem Biol Interact (1993) 0.88
Increased maternal BMI is associated with an increased risk of minor complications during pregnancy with consequent cost implications. BJOG (2009) 0.87
Inhibition of 3,3',4,4',5-pentachlorobiphenyl-induced fetal cleft palate and immunotoxicity in C57BL/6 mice by 2,2',4,4',5,5'-hexachlorobiphenyl. Chemosphere (1997) 0.86
Importance of dose of type II collagen in suppression of collagen-induced arthritis by nasal tolerance. Arthritis Rheum (2001) 0.82
Relative sensitivities of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced Cyp1a-1 and Cyp1a-2 gene expression and immunotoxicity in female B6C3F1 mice. Fundam Appl Toxicol (1994) 0.82
Arthritis: animal models of oral tolerance. Ann N Y Acad Sci (1996) 0.81
Oral tolerance in the control of experimental models of autoimmune disease. Z Rheumatol (1995) 0.79
Increased glycolysis in ageing cultured human diploid fibroblasts. Biosci Rep (1984) 0.78
Hydration and percutaneous absorption: I. Influence of hydration on alkanol permeation through hairless mouse skin. J Invest Dermatol (1980) 0.76
Variation in PAH inputs and microbial community in surface sediments of Hamilton Harbour: implications to remediation and monitoring. Environ Pollut (2007) 0.75
Trigeminal trophic syndrome. Postgrad Med J (1985) 0.75
Hydration and percutaneous absorption III: Influences of stripping and scalding on hydration alteration of the permeability of hairless mouse skin to water and n-alkanols. J Pharm Sci (1982) 0.75
Metabolism and radiosensitization of 4,5-dimethylmisonidazole, a ring-substituted analog of misonidazole. Biochem Pharmacol (1992) 0.75
The effects of oral ginseng administration on the activities and isoenzyme profiles of murine lactate dehydrogenases. Biochem Pharmacol (1984) 0.75
Nasal tolerance to dominant and subdominant epitopes of collagen type II and protection against collagen-induced arthritis. Biochem Soc Trans (1997) 0.75
Pulmonary clearance of vasoactive drugs: N-oxidation of SK&F 86466 in the isolated perfused rat lung. J Pharmacol Exp Ther (1988) 0.75
Immunogenic properties of an anti-DNA antibody-derived peptide, 88H.64-80: location of a dominant idiotope defined by T and B cells. J Autoimmun (1998) 0.75
Neonatal extracorporeal membrane oxygenation in Texas. Tex Med (1990) 0.75
Sedation using remifentanil. Anaesthesia (2003) 0.75